Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: (+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

1021868-76-7

1021868-76-7 structure

1021868-76-7 structure

Name: Lorglumide sodium salt
Chemical Name: Sodium 4-{[4-carboxylato-1-(dipentylamino)-1-oxo-2-butanyl]carbamoyl}-1,2-dichlorobenzene
CAS Number: 1021868-76-7
Molecular Formula: C₂₂H₃₁Cl₂N₂NaO₄
Molecular Weight: 481.388
Catalog: Signaling Pathways GPCR/G Protein Cholecystokinin Receptor
Create Date: 2018-06-20 00:04:31
Modify Date: 2024-01-07 21:19:23
Lorglumide sodium salt (CR-1409 sodium salt) is a potent cholecystokinin (CCK) receptor antagonist[1].

Name	Sodium 4-{[4-carboxylato-1-(dipentylamino)-1-oxo-2-butanyl]carbamoyl}-1,2-dichlorobenzene
Synonyms	Sodium 4-{[4-carboxylato-1-(dipentylamino)-1-oxobutan-2-yl]carbamoyl}-1,2-dichlorobenzene Sodium 4-{[4-carboxylato-1-(dipentylamino)-1-oxo-2-butanyl]carbamoyl}-1,2-dichlorobenzene MFCD00083183

Description	Lorglumide sodium salt (CR-1409 sodium salt) is a potent cholecystokinin (CCK) receptor antagonist[1].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Cholecystokinin Receptor Research Areas >> Metabolic Disease
Target	CCK[1]
References	[1]. Scarpignato C, et al. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat. Br J Pharmacol. 1989 Mar;96(3):661-9.

Molecular Formula	C₂₂H₃₁Cl₂N₂NaO₄
Molecular Weight	481.388
Exact Mass	480.155853
Storage condition	2-8℃

Personal Protective Equipment	Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR	NONH for all modes of transport
RTECS	SA3680700